bupranolol has been researched along with cgp 12177 in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 14 (53.85) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blin, N; Camoin, L; Maigret, B; Strosberg, AD | 1 |
| Guillaume, JL; Méjean, A; Strosberg, AD | 1 |
| Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL | 1 |
| Baker, JG | 1 |
| Endoh, M; Hiramoto, T; Kushida, H | 1 |
| Contreras, ML; Molinoff, PB; Wolfe, BB | 1 |
| Berlan, M; Bousquet-Melou, A; Galitzky, J; Lafontan, M; Montastruc, JL | 1 |
| Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M | 1 |
| Endoh, M; Kohi, M; Norota, I; Takanashi, M | 1 |
| Berlan, M; Carpene, C; Galitzky, J; Lafontan, M; Reverte, M | 1 |
| Hoffstedt, J; Lönnqvist, F; Shimizu, M; Sjöstedt, S | 1 |
| Horinouchi, T; Koike, K; Takayanagi, I | 1 |
| Kaumann, AJ | 1 |
| Koike, K; Takayanagi, I | 1 |
| Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD | 1 |
| Horinouchi, T; Koike, K | 5 |
| Horinouchi, T; Koike, K; Tsujitani, M | 1 |
| Balligand, JL; Donckier, JE; Gauthier, C; Heyndrickx, GR; Massart, PE; Van Mechelen, H | 1 |
| Guibert, C; Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F | 1 |
| Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
| Colledge, WH; Joseph, SS; Kaumann, AJ | 1 |
| Baranowska, M; Baranowska, U; Kiec-Kononowicz, K; Kozlowska, H; Malinowska, B; Reutelsterz, A; Schlicker, E; Zelaszczyk, D | 1 |
26 other study(ies) available for bupranolol and cgp 12177
| Article | Year |
|---|---|
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; GTP-Binding Proteins; Humans; Models, Molecular; Protein Conformation; Receptors, Adrenergic, beta; Signal Transduction; Structure-Activity Relationship | 1993 |
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dithiothreitol; Lipolysis; Propanolamines; Receptors, Adrenergic, beta | 1995 |
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea | 1999 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Preponderance of beta- over alpha-adrenoceptors in mediating the positive inotropic effect of phenylephrine in the ferret ventricular myocardium.
Topics: Adrenergic beta-Antagonists; Animals; Bupranolol; Carnivora; Ferrets; Heart; In Vitro Techniques; Myocardial Contraction; Myocardium; Papillary Muscles; Phenylephrine; Prazosin; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1989 |
Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bupranolol; Cell Line; Computers; Dihydroalprenolol; Kinetics; Mathematics; Pindolol; Propanolamines; Time Factors | 1986 |
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bupranolol; Dioxoles; Dogs; Ethanolamines; Heart Rate; Isoproterenol; Male; Nitroprusside; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow; Skin | 1994 |
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1993 |
On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
Topics: Adrenergic beta-Agonists; Animals; Bupranolol; Calcium; Dogs; Drug Interactions; Ethanolamines; Female; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Phenylephrine; Prazosin; Propanolamines; Rabbits; Receptors, Adrenergic, alpha | 1993 |
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Bupranolol; Dogs; Epinephrine; Fatty Acids, Nonesterified; Insulin; Lipid Metabolism; Lipolysis; Male; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta | 1993 |
Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Bupranolol; Dobutamine; Female; Humans; Lipolysis; Male; Middle Aged; Norepinephrine; Omentum; Propanolamines; Receptors, Adrenergic, beta; Terbutaline | 1995 |
Effect of bupranolol on CGP 12177-induced relaxation and cAMP accumulation in the guinea pig taenia caecum.
Topics: Adrenergic beta-Antagonists; Animals; Bupranolol; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Intestines; Male; Muscle Relaxation; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1995 |
(-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bupranolol; Female; Heart Atria; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Propranolol; Receptors, Adrenergic; Stimulation, Chemical | 1996 |
Characteristics of [3H]CGP12177 binding sites at beta 2- and beta 3-adrenoceptors in the guinea pig taenia caecum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Bupranolol; Butoxamine; Cecum; Guinea Pigs; In Vitro Techniques; Male; Microsomes; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 1997 |
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine | 1999 |
Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bupranolol; Butoxamine; Catecholamines; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3 | 1999 |
[Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastrointestinal tissue systems].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Digestive System; Duodenum; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; Ileum; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta | 1999 |
Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 2000 |
(+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Duodenum; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2001 |
Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Dogs; Ethanolamines; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Propanolamines; Rats; Receptors, Adrenergic, beta-3 | 2000 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atropine Derivatives; Blood Pressure; Bupranolol; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hexamethonium; Hypertension, Renal; Lipolysis; Myocardial Contraction; Nadolol; Propanolamines; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Time Factors | 2001 |
Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Bupranolol; Calcium; Dinoprost; Female; Male; Prazosin; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tritium; Vasoconstriction | 2004 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aspartic Acid; Binding Sites; Bupranolol; CHO Cells; Cricetinae; Cricetulus; Drug Interactions; Isoproterenol; Ligands; Propanolamines; Receptors, Adrenergic, beta-1 | 2004 |
Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Bupranolol; Cerebral Cortex; Male; Propanolamines; Rats; Rats, Wistar; Stereoisomerism; Tachycardia; Xamoterol | 2009 |